Literature DB >> 16947079

Expression and purification of human PAG, a transmembrane adapter protein using an insect cell expression system and its structure basis.

Satoru Takeuchi1.   

Abstract

In this study, we report the purification and structure basis of human phosphoprotein associated with glycosphingolipid-enriched microdomains (PAG), a C-SRC tyrosine kinase (CSK)-binding protein. Human PAG was produced using an insect cell expression system. The PAG was purified by metal affinity, ion exchange, and gel filtration chromatographies. The final purity of gel-purified PAG was evaluated by SDS-PAGE and mass spectrometry. Recombinant human PAG migrates to 60 kDa on SDS-PAGE gel, while native PAG is a 46 kDa transmembrane adapter protein in lipid rafts. Recombinant human PAG has a difference of 2590.7 Da with a calculated mass (47803.41 Da) and an observed mass (50394.1 Da) by mass spectrometry. Consequently, although human PAG sequence shares well-known sites for modifications such as myristoylation, palmitoylation, and tyrosine phosphorylation sites, perhaps the difference suggests the existence of unknown modification sites. We show the high PAG-binding ability with CSK in vitro as well as the human PAG structure characterized by 11 alpha-helix structures including a 3 kDa transmembrane domain.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16947079     DOI: 10.1007/s10930-006-9015-6

Source DB:  PubMed          Journal:  Protein J        ISSN: 1572-3887            Impact factor:   2.371


  11 in total

1.  Interaction between two adapter proteins, PAG and EBP50: a possible link between membrane rafts and actin cytoskeleton.

Authors:  N Brdicková; T Brdicka; L Andera; J Spicka; P Angelisová; S L Milgram; V Horejsí
Journal:  FEBS Lett       Date:  2001-10-26       Impact factor: 4.124

2.  DDBJ in the stream of various biological data.

Authors:  S Miyazaki; H Sugawara; K Ikeo; T Gojobori; Y Tateno
Journal:  Nucleic Acids Res       Date:  2004-01-01       Impact factor: 16.971

3.  Transmembrane phosphoprotein Cbp regulates the activities of Src-family tyrosine kinases.

Authors:  M Kawabuchi; Y Satomi; T Takao; Y Shimonishi; S Nada; K Nagai; A Tarakhovsky; M Okada
Journal:  Nature       Date:  2000-04-27       Impact factor: 49.962

4.  SOPM: a self-optimized method for protein secondary structure prediction.

Authors:  C Geourjon; G Deléage
Journal:  Protein Eng       Date:  1994-02

5.  A simple method for displaying the hydropathic character of a protein.

Authors:  J Kyte; R F Doolittle
Journal:  J Mol Biol       Date:  1982-05-05       Impact factor: 5.469

6.  Transmembrane phosphoprotein Cbp positively regulates the activity of the carboxyl-terminal Src kinase, Csk.

Authors:  S Takeuchi; Y Takayama; A Ogawa; K Tamura; M Okada
Journal:  J Biol Chem       Date:  2000-09-22       Impact factor: 5.157

7.  Cutting edge: negative regulation of immune synapse formation by anchoring lipid raft to cytoskeleton through Cbp-EBP50-ERM assembly.

Authors:  Katsuhiko Itoh; Masahiro Sakakibara; Sho Yamasaki; Arata Takeuchi; Hisashi Arase; Masaru Miyazaki; Nobuyuki Nakajima; Masato Okada; Takashi Saito
Journal:  J Immunol       Date:  2002-01-15       Impact factor: 5.422

8.  BiP is a substrate for src kinase in vitro.

Authors:  A Carlino; H Toledo; V Vidal; B Redfield; J Strassman; M Abdel-Ghany; E Racker; H Weissbach; N Brot
Journal:  Biochem Biophys Res Commun       Date:  1994-06-30       Impact factor: 3.575

9.  Purification and characterization of a novel stress protein, the 150-kDa oxygen-regulated protein (ORP150), from cultured rat astrocytes and its expression in ischemic mouse brain.

Authors:  K Kuwabara; M Matsumoto; J Ikeda; O Hori; S Ogawa; Y Maeda; K Kitagawa; N Imuta; T Kinoshita; D M Stern; H Yanagi; T Kamada
Journal:  J Biol Chem       Date:  1996-03-01       Impact factor: 5.157

10.  Phosphoprotein associated with glycosphingolipid-enriched microdomains (PAG), a novel ubiquitously expressed transmembrane adaptor protein, binds the protein tyrosine kinase csk and is involved in regulation of T cell activation.

Authors:  T Brdicka; D Pavlistová; A Leo; E Bruyns; V Korínek; P Angelisová; J Scherer; A Shevchenko; I Hilgert; J Cerný; K Drbal; Y Kuramitsu; B Kornacker; V Horejsí; B Schraven
Journal:  J Exp Med       Date:  2000-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.